Skip to main content
editorial
. 2020 Oct 28;47(2):101204. doi: 10.1016/j.diabet.2020.10.002

Fig. 1.

Fig. 1

Potential metabolic and inflammatory pathways between COVID-19 and new-onset diabetes. ACE2, angiotension-converting enzyme.2.